Biotech
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 04/23/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") is pleased to announce that Holbrook Koh ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 04/23/13 -- Thallion Pharmaceuticals Inc. (TSX VENTURE: TLN) ("Thallion" or "Company") today announced that it has delayed the date of its 20 ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 04/23/13 -- Theravance, Inc. (NASDAQ: THRX) announced today that Theravance management is scheduled to present at the following investor conferences in May ...
PISCATAWAY, NJ: PISCATAWAY, NJ -- (Marketwired) -- 04/23/13 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that it has concluded a thorough review of the possible sale or disposition of one or more co ...
MOSCOW: MOSCOW -- (Marketwired) -- 04/23/13 -- Cromos™ Pharma, an international full-service CRO with operations in Russia, Ukraine, Georgia and countries of Central/Eastern Europe, announced today the app ...
SAN FRANCISCO, CA: Currently Enrolling Patients in Phase 3 Sickle Cell Clinical Trial, Phase 2 ALI Clinical Trial Scheduled to Commence by Q1 2014 ...
CHAPEL HILL, NC: CHAPEL HILL, NC -- (Marketwired) -- 04/23/13 -- (OTCQB: CWNM) is pleased to announce that it has established a nutraceuticals subsidiary to be known as Crown Nutraceuticals, Inc. Crown Nutraceuticals ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 04/23/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present the Company' ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwired) -- 04/23/13 -- Alchemia Limited (ASX: ACL)Alchemia is eligible to receive up to $240M in milestones, plus R&D expenses and royaltiesCollaboration includes mul ...
PALATINE, IL: PALATINE, IL -- (Marketwired) -- 04/22/13 -- Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating , today announced that the company plans to report financial res ...
BOULDER, CO: BOULDER, CO -- (Marketwired) -- 04/22/13 -- MBio Diagnostics, Inc. announced that it has been collaborating with the Foundation for Innovative New Diagnostics (FIND) on a tuberculosis (TB) serology f ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 04/22/13 -- Arch Biopartners Inc ("Arch" or the "Company")(CNSX: ACH)(OTCBB: FOIFF) today announced Dr. Stephen Robbins and his co-collaborat ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 04/22/13 -- Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced that presentations highlighting Probuphine®, a long-acting, subdermal implant formul ...
LEUVEN, BELGIUM: TiGenixReports Positive Phase IIa Study Results in Refractory Rheumatoid Arthritis With Allogeneic Stem Cell Product Cx611; Management Will Conduct a Conference Call to Discuss the Results Today at 4p ...
TUSTIN, CA: Study to Be Presented as Part of the BioProcess Theater Program Follows a Biologics Production Process From an Early-Stage, Low-Yield Stainless Steel Clinical Process to a High-Yield, Fully-Disposable ...
LONDON, ONTARIO: Dr. Danter to Participate in Round Table Discussion with Gates Foundation ...
BALTIMORE, MD: BALTIMORE, MD -- (Marketwired) -- 04/19/13 -- , a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today an ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 04/19/13 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the Company") today announced its financial results and operational highlights for the ye ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 04/19/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima," the "Company") today released its Appendix 4C - Quarter ...
CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...
